Aspirin for thromboembolic complication prevention in cardiovascular disease: dose optimization and adverse effect minimization
The review is devoted to acetylsalicylic acid (ASC) use in cardiology. Recent epidemiologic surveys demonstrated the important role of thrombosis as a factor provoking exacerbation of coronary heart disease, ischemic stroke, peripheral artery disease. Therefore, antithrombotic and antiplatelet thera...
Saved in:
Main Author: | A. N. Britov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
2006-12-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1407 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Compliance as the major effectiveness determinant in preventive acetylsalicylic acid therapy
by: V. V. Rafalskiy, et al.
Published: (2011-04-01) -
Clinical pharmacology of acetylsalicylic acid as an anti-thrombotic agent
by: V. V. Rafalsky, et al.
Published: (1970-01-01) -
ACETYLSALICYLIC ACID IN LOW DOSES FOR SECONDARY PREVENTION OF CARDIO-VASCULAR COMPLICATIONS
by: N. A. Dmitrieva, et al.
Published: (2016-01-01) -
LONG-TERM THERAPY WITH ACETYLSALICYLIC ACID. HOW TO AVOID THE POSSIBLE COMPLICATIONS?
by: I. V. Zhirov
Published: (2016-01-01) -
ACETYLSALICYLIC ACID AND PREVENTION OF FATAL OUTCOMES IN CARDIOVASCULAR DISEASE: SELECTING MEDICATION FORM AND DOSE
by: O. V. Averkov
Published: (2012-08-01)